trending Market Intelligence /marketintelligence/en/news-insights/trending/mhz6zz6kviwqpgdhxp3bvq2 content esgSubNav
In This List

Affimed appoints chief medical officer

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Affimed appoints chief medical officer

Affimed NV named Leila Alland as its chief medical officer, effective March 26.

Alland was most recently the chief medical officer of Tarveda Therapeutics Inc., a Watertown, Mass.-based developer of drug candidates that target solid tumors.

Prior to joining Tarveda, she was with AstraZeneca PLC as vice president and head of oncology for early clinical development.

Germany-based Affimed works to discover and develop cancer immunotherapies.